We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

67 hedge funds and large institutions have $47.9M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 19

4% more capital invested

Capital invested by funds: $46.1M → $47.9M (+$1.78M)

0.88% more ownership

Funds ownership: 32.69% → 33.57% (+0.88%)

11% less funds holding

Funds holding: 75 → 67 (-8)

73% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 11

Holders
67
Holders Change
-8
Holders Change %
-10.67%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
22
Reduced
19
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IWC
Integrated Wealth Concepts
Massachusetts
+$1.34M
2
Bank of America
Bank of America
North Carolina
+$836K
3
Morgan Stanley
Morgan Stanley
New York
+$806K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$603K
5
PCA
Pallas Capital Advisors
Massachusetts
+$428K

Top Sellers

Rank Fund Capital Flow
1
WBG
Wharton Business Group
Pennsylvania
-$1.06M
2
WAP
Wealthcare Advisory Partners
Pennsylvania
-$990K
3
SFFS
Stonehage Fleming Financial Services
Jersey
-$465K
4
LPL Financial
LPL Financial
California
-$392K
5
AWM
Apollon Wealth Management
South Carolina
-$371K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
51
Steward Partners Investment Advisory
New York
$15.2K – – –
Citigroup
52
Citigroup
New York
$9.34K – – –
NA
53
NewEdge Advisors
Louisiana
$8.17K +$8.39K +350 New
WIM
54
Westside Investment Management
California
$8.16K – – –
TCM
55
TD Capital Management
Tennessee
$7.48K – – –
FDCDDQ
56
Federation des caisses Desjardins du Quebec
Quebec, Canada
$7.01K – – –
TWM
57
Tradition Wealth Management
Minnesota
$6K +$24 +1 +0.4%
NSIM
58
North Star Investment Management
Illinois
$4.67K – – –
TF
59
TimeScale Financial
Massachusetts
$4.41K +$24 +1 +0.5%
HWA
60
HHM Wealth Advisors
Tennessee
$3.15K – – –
BBPWM
61
Blue Bell Private Wealth Management
Pennsylvania
$2.57K – – –
Nomura Asset Management
62
Nomura Asset Management
Japan
$2.33K – – –
AWM
63
Avior Wealth Management
Nebraska
$2.13K – – –
VNA
64
Valley National Advisers
Pennsylvania
$1K – – –
PFM
65
Phillips Financial Management
Indiana
$981 -$37.5K -1,565 -97%
IGWM
66
ICA Group Wealth Management
Colorado
$584 -$600 -25 -50%
AF
67
Advisornet Financial
Minnesota
$280 – – –
SFFS
68
Stonehage Fleming Financial Services
Jersey
– -$465K -20,000 Closed
AWM
69
Apollon Wealth Management
South Carolina
– -$371K -15,938 Closed
LRPA
70
L. Roy Papp & Associates
Arizona
– -$362K -15,555 Closed
Walleye Capital
71
Walleye Capital
New York
– -$292K -12,538 Closed
ASN
72
Advisory Services Network
Georgia
– -$126K -5,400 Closed
BAM
73
Belpointe Asset Management
Nevada
– -$16.1K -691 Closed
KTC
74
Kistler-Tiffany Companies
Pennsylvania
– -$8.14K -350 Closed
Northwestern Mutual Wealth Management
75
Northwestern Mutual Wealth Management
Wisconsin
– -$3.51K -151 Closed
1 2
3
4

IDNA Hedge Fund Activity: Q2 2023 in Review

67 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q2 2023, worth a combined $47.9M — up 3.9% from $46.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of IDNA and 3 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 22 added.

The largest buyer was Integrated Wealth Concepts, adding an estimated $1.34M. The largest seller was Wharton Business Group, cutting an estimated $1.06M.

  • 67 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q2 2023, down from 75 in Q1 2023.
  • Funds reported $47.9M of iShares Genomics Immunology and Healthcare ETF stock for Q2 2023, up 3.9% quarter-over-quarter.
  • 3 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q2 2023 and 11 closed out, a net change of -8 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q2 2023 was Integrated Wealth Concepts, an estimated $1.34M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q2 2023 was Wharton Business Group, an estimated $1.06M sold.

Based on aggregated 13F filings for Q2 2023.